 WALTHAM, Mass.--BUSINESS WIRE--Deciphera Pharmaceuticals, Inc. NASDAQ: DCPH today announced that the Company will host a virtual investor event to review the rebastinib and vimseltinib clinical data to be presented at the upcoming European Society for Medical Oncology ESMO Congress 2021 on Friday, September 17, 2021, from 10:00 AM to 12:30 PM ET. Decipheras senior executive team will be joined by the following key opinion leaders at the event: Dr. Robert L. Coleman, M.D., FACOG, FACS, Gy 